Limb-threatening Ischemia
📧 Sign up to get email alerts when something new happens for Limb-threatening Ischemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Woundsome Revascularization in Chronic Limb-Threatening Ischemia [NA]
This clinical trial update concerns Woundsome Revascularization for Chronic Limb-Threatening Ischemia, sponsored by Assiut University. The s…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Esprit BTK Post-Approval Study [NA]
Update on Abbott's Esprit BTK post-approval study in chronic limb-threatening ischemia. The trial status is ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: REsorbable SCaffolds With everolimUs-Elution for the Treatment of Infrapopliteal Artery Disease in Patients With Chronic Limb-threatening Ischemia
Clinical trial update describing resorbable scaffolds that elute everolimus to treat infrapopliteal artery disease in patients with chronic …
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Can a Dedicated Chronic Limb-threatening Ischaemia (CLTI) Clinic Improve Patient Self-reported Quality of Life
A completed clinical trial evaluated whether a dedicated CLTI clinic improves patients' self-reported quality of life.
-
CLINICAL_TRIALS trial_result · 2024-11-26Clinical Trial Update: Clinical Outcomes Following Surgical Debridement of Diabetic Foot Infection with Borderline Vascularity
This clinical trial update reports outcomes after surgical debridement of diabetic foot infection in patients with borderline vascularity an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-20Clinical Trial Update: Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI Study
The CLariTI study, sponsored by LimFlow, Inc., completed evaluation of the natural progression of high-risk chronic limb-threatening ischemi…
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: PROMISE I Early Feasibility Trial of the LimFlow Stent Graft System [NA]
The PROMISE I early feasibility trial evaluated the LimFlow Stent Graft System for critical limb ischemia and chronic limb-threatening ische…
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: PROMISE II: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia [NA]
Clinical trial update for PROMISE II evaluating percutaneous deep vein arterialization in late-stage chronic limb-threatening ischemia; stat…
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia [Phase 1, Phase 2]
Phase 1/2 trial comparing bone marrow mononuclear cells to mesenchymal stem cells in diabetic patients with chronic limb-threatening ischemi…
-
CLINICAL_TRIALS trial_result · 2021-12-22Clinical Trial Update: Study of AMG0001 to Improve Ulcer Healing and Perfusion in Subjects With Peripheral Ischemic Ulcers [Phase 2]
Phase 2 clinical trial update for AMG0001 evaluating improvement in ulcer healing and perfusion in subjects with peripheral ischemic ulcers.
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Non-Interventional Post Marketing Surveillance Study of Neovasculgen® in Patients With Chronic Lower Limb Ischemia [Phase 4]
Phase 4 non-interventional post-marketing study of Neovasculgen in patients with chronic lower limb ischemia has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Evaluation of Diagnostic Criteria for Chronic Critical Limb Ischemia
A completed clinical study evaluating diagnostic criteria for chronic limb-threatening ischemia, with stroke listed among the conditions.
-
CLINICAL_TRIALS trial_result · 2014-08-22Clinical Trial Update: Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb Ischaemia [Phase 1]
This Phase 1 study assesses safety, pharmacokinetics and pharmacodynamics of multiple doses of BIWH 3 in patients with chronic critical limb…
-
CLINICAL_TRIALS trial_result · 2012-12-13Clinical Trial Update: Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI) [Phase 1, Phase 2]
A Phase 1/2 trial of intra-arterial stem cell therapy for chronic limb-threatening ischemia (CLI) conducted by UMC Utrecht has completed.